@article{418bb8941e2749b1862d71f733473714,
title = "Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells",
abstract = "Chromosomal deletions associated with human diseases, such as cancer, are common, but synteny issues complicate modeling of these deletions in mice. We use cellular reprogramming and genome engineering to functionally dissect the loss of chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the del(7q) iPSCs recapitulate disease-associated phenotypes, including impaired hematopoietic differentiation. These disease phenotypes are rescued by spontaneous dosage correction and can be reproduced in karyotypically normal cells by engineering hemizygosity of defined chr7q segments in a 20-Mb region. We use a phenotype-rescue screen to identify candidate haploinsufficient genes that might mediate the del(7q)- hematopoietic defect. Our approach highlights the utility of human iPSCs both for functional mapping of disease-associated large-scale chromosomal deletions and for discovery of haploinsufficient genes.",
author = "Kotini, {Andriana G.} and Chang, {Chan Jung} and Ibrahim Boussaad and Delrow, {Jeffrey J.} and Dolezal, {Emily K.} and Nagulapally, {Abhinav B.} and Fabiana Perna and Fishbein, {Gregory A.} and Klimek, {Virginia M.} and Hawkins, {R. David} and Danwei Huangfu and Murry, {Charles E.} and Timothy Graubert and Nimer, {Stephen D.} and Papapetrou, {Eirini P.}",
note = "Funding Information: This work was supported by the National Institutes of Health (NIH) grants R00 DK087923 (E.P.P.), R01 HL121570 (E.P.P.), P30 CA15704 and by awards from the University of Washington Royalty Research Fund (E.P.P.), the American Society of Hematology (E.P.P.), the Sidney Kimmel Foundation for Cancer Research (E.P.P.), the Aplastic Anemia & MDS International Foundation (E.P.P.), the Ellison Medical Foundation (E.P.P.), the Damon Runyon Cancer Research Foundation (E.P.P.) and a John H. Tietze Stem Cell Scientist Award (E.P.P.). We thank D. Russell and L. Li for sharing their expertise in AAV-mediated gene targeting and T. Papayannopoulou for sharing her expertise in assessment of May-Giemsa slides and for useful discussions. We thank C. Husser, C. Sather and R. Basom for excellent technical assistance and J. Overbey for statistical advice. Publisher Copyright: {\textcopyright} 2015 Nature America, Inc. All rights reserved.",
year = "2015",
month = jun,
day = "11",
doi = "10.1038/nbt.3178",
language = "English (US)",
volume = "33",
pages = "646--655",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "6",
}